Author:
Niparuck Pimjai,Limsuwanachot Nittaya,Pukiat Sulada,Chantrathammachart Pichika,Rerkamnuaychoke Budsaba,Magmuang Sutada,Phusanti Sithakom,Boonyawat Kochawan,Puavilai Teeraya,Angchaisuksiri Pantep,Ungkanont Artit,Chuncharunee Suporn
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Reference32 articles.
1. Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358(18):1909–18.
2. Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–47.
3. Ling Y, Xie Q, Zhang Z, Zhang H. Protein kinase inhibitors for acute leukemia. Biomark Res. 2018;6(8):1–7.
4. Wu M, Li C, Zhu X. FLT3 inhibitors in acute myeloid leukemia. J Hematol Oncol. 2018;11(133):1–11.
5. Gu R, Yang X, Wei H. Molecular landscape and targeted therapy of acute myeloid leukemia. Biomark Res. 2018;6(32):1–8.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献